Is Trump’s most-favoured-nation drug policy keeping medicine from Canada? Evidence is mixed
The Globe and Mail · Chris Hannay ·
MFN deals force drug companies to lower prices in the U.S. by raising them in other countries
Read the full story at The Globe and Mail · All coverage of this story